Hong Yu

Hong Yu

Auto-generated profile, based on publicly available information

Hong Yu

Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HYHong Yu
Hong Yu
HYHui Yu
Hui Yu
LSLengge Si
Lengge Si
HMHusileng Meng
Husileng Meng
WCWensheng Chen
Wensheng Chen
AGA. Gula
A. Gula
Background: Insomnia is the most common of the sleep disorders. Current pharmacotherapy treatment options are usually associated with adverse effects and withdrawal phenomena. Therapeutic alternatives with a more favorable safety profile for patients are needed. Mongolian medical warm acupuncture (MMWA) is an emerging therapeutic option for treating insomnia. However, the underlying mechanisms responsible for the anti-insomnia efficacy of the MMWA remain unclear. This study aims to investigate the effect of the MMWA on the alterations of the gut microbiota and serum metabolome in rats with insomnia.Results: We found that the relative abundances of gut bacteria and the concentrations of several serum metabolites were obviously altered in PCPA-induced insomnia rats. The MMWA treatment exerted an anti-insomnia effect. In addition, the dysbiosis of the gut microbiota and the serum metabolites were ameliorated by the MMWA. Correlation analysis between the gut microbiota and metabolites suggested that the levels of Amide c18, Benzoyl chloride, Cytosine, and N, n-dimethylarginine were positively correlated with the relative abundance ofClostridium XlVaandBlautia, which characterized the insomnia rats. KEGG enrichment analysis identified the cAMP signaling pathway involving anti-insomnia effect of the MMWA. Moreover, the MMWA intervention significantly increased contents of butyrate in feces, while effectively inhibited the expression level of GAT-1 in brain tissues.Conclusion: This study reveals that the MMWA intervention might have a major impact on the modulation of host gut microbiota and metabolites, which in turn have a crucial role in the regulation of the host’s signaling pathways associated with insomnia. The present study could provide useful ideas for the study of the intervention mechanisms of the MMWA in insomnia rat models.

1 January 2025 in Archives of Biological Sciences
Verified
Journal Article
Open access
PDF file
HMHusileng Meng
Husileng Meng
HYHong Yu
Hong Yu
SGSuhe Gang
Suhe Gang
GAGula A
Gula A
ZWZhanli Wang
Zhanli Wang
The study was designed to determine whether Mongolian medical warm acupuncture (MMWA) can alleviate neuropathic pain through regulating gut microbiota and inflammation-related pathways in the chronic constriction injury (CCI) rat model. Rats were randomly divided into three groups: sham, model, and treatment. A bilateral chronic constriction injury (CCI) was induced to establish a rat model of neuropathic pain. Rats in the treatment group received MMWA at the Heyi and Shen acupoints once daily for seven consecutive days. Pain-related behaviors were evaluated using mechanical pain threshold and thermal withdrawal latency measurements. The mRNA levels of c-fos in spinal dorsal horns were determined using real-time PCR. Gut microbiota was analyzed by 16S ribosomal RNA sequencing. Interleukin (IL)-1?, IL-6, and tumor necrosis factor (TNF)-? were evaluated by enzyme-linked immunosorbent assay (ELISA) analysis. MMWA could relieve behavioral symptoms (P<0.01). MMWA intervention significantly suppressed the expression of c-fos in CCI rats (P<0.05). The relative abundance of gut bacteria was disturbed in CCI rats, with the microbiota disorder ameliorated by MMWA. KEGG enrichment analysis revealed that changes in gut microbiota were associated with the pentose and glucuronate interconversion pathway and secondary bile acid biosynthesis. The concentrations of IL-1?, IL-6, and TNF-? in CCI rats were increased (P<0.05), an effect that was reversed by MMWA intervention (P<0.05). The current study indicated that the MMWA could effectively alleviate neuropathic pain by modulating gut microbiota and inhibiting inflammation in the CCI rat model, suggesting that gut microbiota could be a promising potential biological target for treating neuropathic pain.